Evidence map›Paper›PMID 36506936›Full record

ArticleOxidative medicine and cellular longevity2022

Breast Cancer Exosome-Derived miR-425-5p Induces Cancer-Associated Fibroblast-Like Properties in Human Mammary Fibroblasts by TGF

Yue Zhu, He Dou, Yuqi Liu, Pingyang Yu, Fucheng Li, Youyu Wang, Min Xiao

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yue ZhuDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081 Heilongjiang, China.ORCID https://orcid.org/0000-0001-7719-9263
He DouDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081 Heilongjiang, China.
Yuqi LiuDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081 Heilongjiang, China.
Pingyang YuDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081 Heilongjiang, China.
Fucheng LiDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081 Heilongjiang, China.
Youyu WangDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081 Heilongjiang, China.
Min XiaoDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, 150081 Heilongjiang, China.ORCID https://orcid.org/0000-0001-8077-453X
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The connection between the cellular microenvironment and tumor cells is crucial for tumor progression. However, the process by which normal fibroblasts (NFs) become cancer-associated fibroblasts (CAFs) is unknown, and mounting evidence suggests that some microRNAs (miRNAs) have an important role in converting NFs into CAFs. Breast cancer (BC) has been proven to have enhanced miR-425-5p expression in order to support progression. We discovered that human mammary fibroblasts (HMFs) could uptake BC cell line-derived exosomes to change their properties, promoting the switch to the CAF phenotype and increasing cell motility, as evidenced by an increase in CAF activation-related marker protein expression and cell proliferation, invasion, and migration. Transfection of exosomes is obtained from BC cells, and miR-425-5p inhibitors suppressed the aforementioned effects as well as lowered chemokine levels and gene expression related with proliferation and metastasis. By suppressing the expression of its target gene TGF

Indexed as

Breast NeoplasmsCancer-Associated FibroblastsMicroRNAsCell Line, TumorCell MovementCell ProliferationFemaleFibroblastsGene Expression Regulation, NeoplasticHumansSignal TransductionTumor MicroenvironmentMicroRNAsMIRN425 microRNA, human

Identifiers

PMID36506936
PMCPMC9729028
OpenAlexW4311121945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.